NEOCLONE

Through a lot of hard work, a license from the Wisconsin Alumni Research Foundation (WARF) and a desire to have an impact on human health, NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies. As they refined the process to make better antibodies (what is now the NeoAb process), they established a service business to make high-quality antibodies for others... Let NeoClone help you develop monoclonal antibodies against your very challenging target. Do you need Llama VHH, human scFv or traditional mouse hybridomas? Give us a call, and we'll get you started on the road to your custom antibody... To poise ourselves for future success, we've continued to refine our antibody development abilities. In 2014, we added antibody phage display technology to help us develop the diverse and specific antibody repertoire to certain difficult targets that might be difficult to achieve with hybridoma..

Primary location: Madison United States